Abstract
The pharmacological treatment of cystic fibrosis, together with implications for health economics, therapeutic monitoring and adherence, are discussed
Original language | English |
---|---|
Pages (from-to) | 47-50 |
Number of pages | 4 |
Journal | Hospital Pharmacy Europe |
Volume | 73 |
Publication status | Published - Apr 2014 |
Keywords
- cystic fibrosis
- health economics
- treatment
- airways disease
- antibiotics
- mucolytics
- adherence
- therapeutic monitoring
- CFTR
- health costs
- Respiratory infections
- hospitalisation